COVID-19: You can find information and stay up-to-date on the latest support for business on our coronavirus page or by calling 13 28 46.×


Time: 0

Vaxxas is disrupting and revolutionizing the way vaccines are delivered, through their innovative Nanopatch™.

The R&D Tax Incentive helped attract further investment in our company and open up more chances for collaboration with large pharma companies, universities and philanthropic organisations around the world.

Angus Foster, Chief Development and Operations Manager, Vaxxas

Company Profile

Company: Vaxxas Pty Ltd

Sector: Biotechnology

Location: Brisbane

Profile: Vaxxas is a medical technology start-up located in Brisbane, revolutionizing the way vaccines are delivered. Vaccinations have historically been given using syringes and needles; however through Research & Development, Vaxxas has been able to develop their Nanopatch – a less invasive vaccine delivery technology that creates a more potent immune response.